Insulin Assistance Programs: Big Help Or Just A Band-Aid?
Executive Summary
Drug makers and other stakeholders have been rolling out insulin savings programs as the high cost of insulins come under scrutiny on Capitol Hill. Sanofi announced an expanded cost-savings program during a House hearing, but one Congresswoman called them a band-aid.
You may also be interested in...
UnitedHealthcare Announces Zero Cost Sharing For Insulin As Legislative Relief Faces Challenges
Private sector efforts to lower cost sharing for insulin continue but patient advocates and lawmakers still believe legislation is needed to tackle the issue in a comprehensive way.
Insulin Prices: House Hearing Displays Bipartisan Commitment To Rapid Reform
Reform "is going to happen,” promised Energy & Commerce Oversight Subcommittee Chair Diana DeGette, suggesting the panel’s next hearing on insulin price reform may be held in July.
PBMs Were On Capitol Hill, But Pharma Still Took Some Heat
Drug makers remained front and center during the Senate Finance Committee's third hearing on drug pricing, even though leaders from five pharmacy benefit managers were testifying.